Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 220

Worldwide Diabetes Will Double By 2030<br>Issue 220 Item 13

U.S. will have over 30 million,but the most significant increases are expected in the Middle East, sub-Saharan Africa and India.
Advertisement
The number of people with diabetes throughout the world is expected to double by 2030, according to a new study led by the World Health Organization and carried out in cooperation with researchers from universities in Scotland, Denmark and Australia.

The researchers, led by Sara Wild, PhD, from the University of Edinburgh, predicted that the number of people with diabetes worldwide will continue to increase at record levels through 2030. Wild and her colleagues said the greatest relative increase in diabetes prevalence is expected in the Middle Eastern, sub-Saharan Africa and India. The researchers also said that the United States will experience a far more rapid increase in diabetes cases than previously expected.

Wild and her colleagues arrived at these predictions by analyzing data on diabetes prevalence in countries throughout the world. The researchers said the worldwide prevalence of diabetes for all age groups was estimated to be 2.8% in 2000. But the researchers predict this number will increase to 4.4% by 2030. They also predicted that the total number of people with diabetes will rise to 366 million in 2030, up from 171 million in 2000.

The three countries with the highest prevalence of diabetes in 2000 were India, China and the United States. The researchers said these countries are expected to continue to have the highest prevalence in 2030.

But this new study projects an even higher increase for the United States than a 2001 study by the CDC had previously predicted. That study projected the number of Americans with diagnosed diabetes would reach 29 million by 2050; but this new WHO study estimates that there will be 30.3 million Americans with diabetes by as early as 2030.

Wild and her colleagues also predicted that Egypt and the Philippines will be among the top 10 countries with the highest prevalence of diabetes by 2030. But they said Italy and Russia are expected to drop from this list.

The researchers said their findings are particularly concerning because as diabetes is expected to increase in developing countries over the next three decades, mortality from communicable disease and infant and maternal mortality will decrease. Wild and her colleagues said this change will lead to higher proportions of deaths from cardiovascular disease, as well as a great incidence of other diabetes-related complications, which will be particularly marked in developing countries. “The human and economic costs of this epidemic are enormous,” Wild and her colleagues noted. “A concerted, global initiative is required to address the diabetes epidemic.”

Wild S. et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
================================

FACT: One can of coke contains nearly 10 teaspoons of sugar or the entire daily recommended amount of calories from sugar.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 10 August, 2004 and appeared in  Issue 220

Past five issues: Diabetes Clinical Mastery Series Issue 216 | Issue 756 | Diabetes Clinical Mastery Series Issue 215 | SGLT-2 Inhibitors Special Edition November 2014 | Issue 755 |

2014 Most Popular Articles:

New SGLT2 Inhibitor Likely To Be Approved for Type 2 Diabetes
Posted November 14, 2014
Grapefruit Juice May Affect Insulin Resistance
Posted October 23, 2014
New Approach Targets Type 2's Poorly Controlled With Metformin
Posted November 14, 2014
Very Low Carbohydrate, Low Saturated Fat Diet for Type 2 Diabetes Management
Posted November 07, 2014
Dietary Magnesium Intake's Role in Decreasing Metabolic Syndrome
Posted October 31, 2014
FDA Accepts Filing of NDA for Empagliflozin/Metformin Fixed-dose Combination
Posted October 23, 2014
Handbook of Diabetes, 4th Ed., Excerpt #16: Diabetic Neuropathy
Posted November 02, 2014
What's Hiding in that Insulin Box?
Posted October 27, 2014
Exercise Promotes Preservation of Beta Cells
Posted November 14, 2014
Interview with NuSirt CEO Joe Cook, Jr: Improving Metformin Treatment, Part 1
Posted November 02, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
If the U.S. Affordable Care Act is reversed in the new congress, what impact will that have on your patients?



Search Articles On Diabetes In Control